Sildenafil does not influence hepatic venous pressure gradient in patients with cirrhosis | Zendy

Jens Otto Clemmesen | Zendy; Annamaria Giraldi | Zendy; Peter Ott | Zendy; Kim Dalhoff | Zendy; Bent Adel Hansen | Zendy; Fin Stolze Larsen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Sildenafil does not influence hepatic venous pressure gradient in patients with cirrhosis

Author(s) -

Jens Otto Clemmesen,

Annamaria Giraldi,

Peter Ott,

Kim Dalhoff,

Bent Adel Hansen,

Fin Stolze Larsen

Publication year - 2008

Publication title -

world journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.427

H-Index - 155

eISSN - 2219-2840

pISSN - 1007-9327

DOI - 10.3748/wjg.14.6208

Subject(s) - medicine , sildenafil , portal venous pressure , cirrhosis , splanchnic , portal hypertension , blood pressure , blood flow , liver disease , splanchnic circulation , anesthesia , cardiology , gastroenterology

To investigate if sildenafil increases splanchnic blood flow and changes the hepatic venous pressure gradient (HVPG) in patients with cirrhosis. Phosphodiesterase type-5 inhibitors are valuable in the treatment of erectile dysfunction and pulmonary hypertension in patients with end-stage liver disease. However, the effect of phosphodiesterase type-5 inhibitors on splanchnic blood flow and portal hypertension remains essentially unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research